60 customized services results for

and VEGFR would activate luciferase reporter gene expression.

It is a milestone on the path to industrialization of the cell and gene therapy industry, pioneered by

trials, and has successfully delivered a number of CMC and GMP production projects.ProBio 's integrated gene

AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.ProBio

We will be able to meet the rapidly evolving demands of gene, cell, antibody and protein therapies.

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market

FilingAAV vector is widely used delivery vehicle due to its high safety and effectiveness in delivering Gene

synthesis to Top 6 clones14 weeks from gene synthesis to Top 1 clone Excellent DeliverablesAntibody

FeaturesOver 200 tumor cell lines, over 200 target-overexpressing stable cell lines, over 10 reporter gene

expedited timeline, good Ab sequence diversity and better cost-effectiveness.Case Study: TIGIT RGA Reporter Gene